id: NEW:mental_health_treatment_research_infrastructure_to_NEW:evidence_based_treatment_availability_aspd
name: Mental Health Treatment Research Infrastructure â†’ Evidence-Based Treatment Availability for AsPD
from_node:
  node_id: NEW:mental_health_treatment_research_infrastructure
  node_name: Mental Health Treatment Research Infrastructure
to_node:
  node_id: NEW:evidence_based_treatment_availability_aspd
  node_name: Evidence-Based Treatment Availability for AsPD
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Limited research investment in personality disorder pharmacotherapy results in small, unreplicated
  studies'
- 'Step 2: Only 11 studies over decades, with data available from only 4 studies (274 participants)'
- 'Step 3: Insufficient evidence base prevents development of clinical guidelines'
- 'Step 4: Clinicians lack evidence-based pharmacological treatment options for AsPD'
evidence:
  quality_rating: B
  n_studies: 11
  primary_citation: Najat R Khalifa et al. 2020. "Pharmacological interventions for antisocial personality
    disorder.." https://doi.org/10.1002/14651858.CD007667.pub3
  supporting_citations:
  - All available data came from unreplicated, single reports
  - Data did not allow independent statistical analysis
  - Study duration ranged from 6 to 24 weeks with no follow-up period
  doi: 10.1002/14651858.CD007667.pub3
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: 'The systematic review reveals profound structural gaps in mental health research: only 11
  RCTs exist for pharmacological treatment of AsPD, with extractable data from only 4 studies involving
  274 participants. All findings come from unreplicated single reports of mostly older medications, preventing
  evidence-based clinical recommendations.'
quantitative_effects:
  sample_size: 274
spatial_variation:
  varies_by_geography: true
  variation_notes: 10/11 studies conducted in North America; global research infrastructure for AsPD treatment
    even more limited
moderators:
- name: medication_class
  direction: strengthens
  strength: weak
  description: Only three drug classes studied (antiepileptic, antidepressant, dopamine agonist) with
    mostly older medications, limiting therapeutic options
structural_competency:
  equity_implications: This mechanism exposes how structural underinvestment in mental health research
    perpetuates health inequities. AsPD is associated with criminality, unemployment, relationship difficulties,
    and premature death, yet receives minimal research attention compared to other psychiatric conditions.
    The population affected disproportionately includes those already marginalized by criminal justice
    involvement, substance use disorders, and socioeconomic disadvantage. The lack of evidence-based treatments
    represents a failure of healthcare systems to address a condition with significant public health burden
    and equity implications.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.353870'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
